DNA PROFILE LTD

PERME is a disruptive digital health platform that converts DNA samples into real-time data via a unique device, removing lab needs. Backed by experts in nanotech, MEMS, genetics, and RF engineering, PERME targets a $500B market with a B2B'C model

PerMe's core technology is a proprietary lab-free DNA biosensor: a single-use, disposable chip-based sensor that detects genetic variations directly from a biological sample and converts them into digital output without laboratory processing or conventional microelectronic components. Results are transmitted directly to a mobile device within minutes. The device architecture draws on nanotechnology, MEMS (Micro-Electro-Mechanical Systems), and RF engineering, developed with input from specialists in genetics, longevity, and bioinformatics. A software layer converts the resulting biological data into health, beauty, and wellness recommendations, with a planned extension to apply data analytics and AI/ML models to the aggregated dataset.

Disease detection, beauty and wellness, supplements and medication compatibility aspects.

Yoav Rapaport - CEO & Co-Founder

Igal Chertkow - CTO & Co-Founder